CBG Benefits: What Does Research Explore About Cannabigerol?

CBG — cannabigerol — is one of the most scientifically interesting minor cannabinoids in the cannabis plant. While THC and CBD dominate public awareness, CBG occupies a unique position in cannabinoid science: it serves as the chemical starting point from which the plant produces other cannabinoids, and it interacts with biological systems in ways that researchers are only beginning to map. This article explores what current scientific literature examines in relation to CBG, across a range of research areas from inflammation to neuroprotection.

What Is CBG (Cannabigerol)?

CBG stands for cannabigerol. The cannabis plant produces it directly, making it one of the primary cannabinoids rather than a breakdown product. More precisely, the plant first produces CBGA — the acidic form of CBG — which enzymes then convert into THCA, CBDA, and CBCA as the plant matures. The remaining CBGA becomes CBG. This is why researchers call CBG the “mother of all cannabinoids” — it sits at the root of the plant’s entire cannabinoid production chain.

CBG is non-intoxicating. It does not produce the psychoactive effects associated with THC. Most cannabis plants produce CBG in very small amounts — typically under 1% — because most CBGA converts into other cannabinoids before harvest. Some plant varieties are bred specifically to retain higher CBG concentrations.

CBG vs CBD: How Do They Compare?

CBG and CBD are both non-intoxicating cannabinoids, but they differ meaningfully in how they form, how much research exists behind them, and how they interact with the body.

• Origin: CBD comes directly from the plant in large amounts. CBG also comes directly from the plant but in far smaller quantities.
• Research volume: CBD has a substantially larger body of clinical research. CBG research is earlier stage but growing rapidly.
• ECS interaction: CBD interacts indirectly with CB1 and CB2 receptors and engages several other receptor systems. CBG binds more directly to both CB1 and CB2 receptors.
• Anti-inflammatory research: Both cannabinoids appear in anti-inflammatory research. Studies examine each separately and together in inflammatory models.
• Psychoactivity: Neither compound is intoxicating at standard amounts. Science classes both as non-psychoactive.

What Research Areas Cover CBG?

Researchers study CBG across several distinct areas in laboratory and animal model settings. Here is an overview of the main research contexts and what studies have explored so far.

Inflammation and Inflammatory Bowel Disease

A 2013 study published in Biochemical Pharmacology examined CBG in a mouse model of inflammatory bowel disease (IBD). Researchers observed that CBG reduced markers of intestinal inflammation in that model. Anti-inflammatory activity is one of the most studied properties of CBG across multiple experimental contexts. Studies examine this property both in isolation and alongside other cannabinoids.

Bladder Function Research

A 2015 study investigated how several cannabinoids interact with bladder contraction mechanisms. CBG was among the cannabinoids examined. Researchers observed that CBG showed notable activity in that experimental model. As with all preclinical cannabinoid research, these findings require clinical validation before any conclusions can apply to human bladder conditions.

Neuroprotection and Huntington’s Disease Models

CBG’s neuroprotective properties have attracted research interest in the context of neurodegenerative conditions. In a study using a mouse model of Huntington’s disease — a progressive neurological condition affecting movement, mood, and cognition — researchers examined CBG’s effects on markers of neurodegeneration. CBG demonstrated antioxidant and anti-inflammatory activity in that model, which the researchers considered relevant to neuronal protection. Human clinical studies in this area are currently lacking.

Ocular Pressure and Glaucoma Research

Researchers have studied cannabinoids including CBG in relation to intraocular pressure — the elevated eye pressure that plays a central role in glaucoma. A study published in 2008 examined CBG alongside other cannabinoids in this context and observed that CBG produced a measurable reduction in intraocular pressure in that experimental model. The authors identified this as a potentially relevant finding for further investigation. Clinical research in humans remains limited.

Cellular Research and Cancer Biology Models

A 2014 study examined CBG in a colorectal cancer cell model and observed that CBG inhibited the growth of cancer cells and tumour progression markers in that setting. A separate 2014 study explored CBG in a colon cancer model and observed similar inhibitory activity. These are laboratory and animal studies — they explore cellular mechanisms and do not constitute evidence that CBG prevents or treats cancer in humans. Researchers describe these findings as early-stage and in need of extensive clinical follow-up.

CBG, GABA, and Muscle Relaxation Research

One of the more studied aspects of CBG is its interaction with GABA — gamma-aminobutyric acid — the main inhibitory neurotransmitter in the central nervous system. GABA plays a significant role in regulating muscle tone, anxiety, and sleep-related pathways.

Research suggests that CBG may inhibit the reuptake of GABA, allowing it to remain active in the synapse for longer. Some studies indicate that CBG’s activity at GABA pathways may be more pronounced than that observed with CBD or THC in the same models, though this finding is based on limited preclinical data and requires further investigation. Researchers explore these interactions in the context of muscle spasm, anxiety, and sleep regulation. No clinical trials currently confirm these effects in humans.

What Does Research Say About CBG Safety?

Animal studies generally report that CBG is well tolerated at the doses studied. Rodent research has not identified significant adverse effects at standard experimental amounts. However, human safety data for CBG specifically remains very limited. The absence of widely reported negative effects in the available literature reflects the early stage of CBG research rather than confirmed safety in humans.

As with any cannabinoid supplement, always consult a qualified healthcare professional before use — particularly if you take prescription medication or have an existing health condition.

What to Look for in a CBG Product

The CBG supplement market is still developing. When choosing any CBG product, the same quality markers apply as with any cannabinoid oil:

• An independent Certificate of Analysis (COA) confirming actual cannabinoid content
• Batch number traceability linking the product you receive to its COA
• THC-free (0.0%) or below 0.3% THC verified by third-party testing
• EU-grown hemp with transparent sourcing
• Clear ingredient labelling including carrier oil type

Canna Health Amsterdam CBG and CBD oils carry the CAN mark from Cannabinoïden Adviesbureau Nederland, confirming formal registration under Dutch food supplement regulations as fit for consumption — without the ‘not for human consumption’ disclaimer most other brands must display.

Conclusion

CBG is one of the most scientifically interesting minor cannabinoids in current research. Studies examine it in relation to inflammation, bladder function, neuroprotection, ocular pressure, cellular biology, and GABA-related pathways. Across all of these areas, the evidence base is preclinical or limited to small studies — but the breadth of research directions is notable.

tmlAs cannabinoid science develops, CBG is likely to attract increasing research attention. For now, it represents a genuinely promising but early-stage area of scientific inquiry.

Disclaimer: This blog is for informational and educational purposes only. We review and reference available studies and reputable sources; however, content may not reflect the most current research or regulations and should not be taken as medical, legal, or professional advice. We do not make or imply health claims. Products mentioned are not intended to diagnose, treat, cure, or prevent any disease and statements have not been evaluated by EFSA or the FDA. Effects can vary between individuals. Always consult a qualified healthcare professional before use and verify that any product or ingredient is lawful in your jurisdiction.